2-[4-[(5-amino-7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methoxymethyl]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol

C21H17F6N5O3 — CID 162684898

IUPAC2-[4-[(5-amino-7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methoxymethyl]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol
SMILESCOc1cccc2c1nc(N)n1nc(COCc3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)nc21
InChIInChI=1S/C21H17F6N5O3/c1-34-14-4-2-3-13-16(14)30-18(28)32-17(13)29-15(31-32)10-35-9-11-5-7-12(8-6-11)19(33,20(22,23)24)21(25,26)27/h2-8,33H,9-10H2,1H3,(H2,28,30)
InChIKeyHIFISYXNKOESGU-UHFFFAOYSA-N
MW501.39 g/mol
LogP3.90
Rot. Bonds6

About 2-[4-[(5-amino-7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methoxymethyl]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol

2-[4-[(5-amino-7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methoxymethyl]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol (PubChem CID 162684898) has the molecular formula C21H17F6N5O3 and a molecular weight of 501.39 g/mol. Its IUPAC name is 2-[4-[(5-amino-7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methoxymethyl]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol.

Molecular Properties

Compound Name2-[4-[(5-amino-7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methoxymethyl]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol
PubChem CID162684898
Molecular FormulaC21H17F6N5O3
Molecular Weight501.39 g/mol
Exact Mass501.12
IUPAC Name2-[4-[(5-amino-7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methoxymethyl]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol
SMILESCOc1cccc2c1nc(N)n1nc(COCc3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)nc21
InChIInChI=1S/C21H17F6N5O3/c1-34-14-4-2-3-13-16(14)30-18(28)32-17(13)29-15(31-32)10-35-9-11-5-7-12(8-6-11)19(33,20(22,23)24)21(25,26)27/h2-8,33H,9-10H2,1H3,(H2,28,30)
InChIKeyHIFISYXNKOESGU-UHFFFAOYSA-N
XLogP3.90
TPSA107.79 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds6
Heavy Atoms35
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500501.39
LogP ≤ 53.90
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Analyze 2-[4-[(5-amino-7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methoxymethyl]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[4-[(5-amino-7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methoxymethyl]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol?
The IUPAC name of 2-[4-[(5-amino-7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methoxymethyl]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol (CID 162684898) is 2-[4-[(5-amino-7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methoxymethyl]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol.
What is the SMILES notation for 2-[4-[(5-amino-7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methoxymethyl]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol?
The canonical SMILES for 2-[4-[(5-amino-7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methoxymethyl]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol is COc1cccc2c1nc(N)n1nc(COCc3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)nc21.
What is the InChIKey of 2-[4-[(5-amino-7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methoxymethyl]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol?
The InChIKey is HIFISYXNKOESGU-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H17F6N5O3/c1-34-14-4-2-3-13-16(14)30-18(28)32-17(13)29-15(31-32)10-35-9-11-5-7-12(8-6-11)19(33,20(22,23)24)21(25,26)27/h2-8,33H,9-10H2,1H3,(H2,28,30).
What are the key properties of 2-[4-[(5-amino-7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methoxymethyl]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol?
2-[4-[(5-amino-7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methoxymethyl]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol has a molecular weight of 501.39 g/mol, XLogP of 3.90, 6 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-[(5-amino-7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methoxymethyl]phenyl]-1,1,1,3,3,3-hexafluoropropan-2-ol is sourced from PubChem (CID 162684898), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).